BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33994731)

  • 1. GATA-3 Expression in all Grades and Different Variants of Primary and Metastatic Urothelial Carcinoma.
    Naik M; Rao BV; Fonseca D; Murthy SS; Giridhar A; Sharma R; Raju K; Rao TS; Challa S
    Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):72-78. PubMed ID: 33994731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
    Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary carcinoma of renal calyx.
    Williams PA; Mai KT
    Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of GATA-3 in urothelial carcinoma variants.
    Liang Y; Heitzman J; Kamat AM; Dinney CP; Czerniak B; Guo CC
    Hum Pathol; 2014 Jul; 45(7):1466-72. PubMed ID: 24745616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma.
    Montoya-Cerrillo D; Briski LM; Jorda M; Kryvenko ON
    Int J Surg Pathol; 2022 May; 30(3):260-264. PubMed ID: 34665053
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
    Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE
    Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of p63, p40, and GATA-binding protein 3 immunohistochemistry in diagnosing micropapillary urothelial carcinoma.
    Lin X; Zhu B; Villa C; Zhong M; Kundu S; Rohan SM; Yang XJ
    Hum Pathol; 2014 Sep; 45(9):1824-9. PubMed ID: 24993315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of urothelial carcinoma.
    Rajcani J; Kajo K; Adamkov M; Moravekova E; Lauko L; Felcanova D; Bencat M
    Bratisl Lek Listy; 2013; 114(8):431-8. PubMed ID: 23944616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Relevance of GATA 3 Expression in Urinary Bladder Carcinoma of Divergent Differentiation and Other Histological Variants.
    Rana C; Babu S; Agarwal H; Singhai A; Kumar M; Singh V; Sinha RJ; Shankhwar SN
    Indian J Surg Oncol; 2021 Dec; 12(4):678-685. PubMed ID: 35110887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Cox R; Epstein JI
    Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of uroplakin II expression as a marker of urothelial carcinoma.
    Tian W; Guner G; Miyamoto H; Cimino-Mathews A; Gonzalez-Roibon N; Argani P; Li X; Sharma R; Subhawong AP; Rezaei K; Bivalacqua TJ; Epstein JI; Bishop JA; Netto GJ
    Hum Pathol; 2015 Jan; 46(1):58-64. PubMed ID: 25449628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive urothelial carcinoma exhibiting basal cell immunohistochemical markers: A variant of urothelial carcinoma associated with aggressive features.
    Mai KT; Truong LD; Ball CG; Williams P; Flood TA; Belanger EC
    Pathol Res Pract; 2015 Aug; 211(8):610-8. PubMed ID: 26100813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of pagetoid urothelial intraepithelial neoplasia extending to the vagina by cervical screening cytology: a case report with renewed immunochemical summary.
    Koyanagi Y; Kubo C; Nagata S; Ryu A; Hatano K; Kano R; Tanada S; Ashimura JI; Idota A; Kamiura S; Yamasaki T; Nakatsuka SI
    Diagn Pathol; 2019 Feb; 14(1):9. PubMed ID: 30711015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive high-grade urothelial carcinoma of the bladder, renal pelvis, ureter, and prostatic urethra arising in a background of urothelial carcinoma with an inverted growth pattern: a contemporary clinicopathological analysis of 91 cases.
    Gutierrez CM; Alemozaffar M; Osunkoya AO
    Hum Pathol; 2019 Oct; 92():18-24. PubMed ID: 31351154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of uroplakin III in distinguishing variants of primary bladder urothelial carcinoma from malignancy metastatic to the urinary bladder.
    Klopfer K; Delahunt B; Adamson M; Samaratunga H
    Anticancer Res; 2014 Nov; 34(11):6779-84. PubMed ID: 25368291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
    Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
    Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical staining characteristics of nephrogenic adenoma using the PIN-4 cocktail (p63, AMACR, and CK903) and GATA-3.
    McDaniel AS; Chinnaiyan AM; Siddiqui J; McKenney JK; Mehra R
    Am J Surg Pathol; 2014 Dec; 38(12):1664-71. PubMed ID: 24921643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma.
    Oh WJ; Chung AM; Kim JS; Han JH; Hong SH; Lee JY; Choi YJ
    J Pathol Transl Med; 2016 Sep; 50(5):345-54. PubMed ID: 27498545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
    Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
    Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.